The pronounced overexpression of PAPP-A in breast cancer cases, including those associated with PABC, underscores its potential utility as a marker for aggressive disease forms and as a focal point for therapeutic interventions [24,25]. The gene discussed is PAPPA; the disease is breast carcinoma.